Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non-small cell lung cancer.
Eiji IwamaHidetaka YamamotoFumihiko OkuboKayo IjichiRitsu IbusukiYoshimasa ShiaraishiYasuto YoneshimaKentaro TanakaYoshinao OdaIsamu OkamotoPublished in: Thoracic cancer (2023)
Our findings indicate that a TS of ≥4000 is a feasible and relevant criterion for ODxTT testing, and its adoption should help to improve the success rate of such testing in clinical practice.